Seven Fleet Capital Management LP 13F Holdings · Q2 2026
Seven Fleet Capital Management LP reported 96 securities worth $605.92M in its SEC 13F filing for Q2 2026 (period ended 2026-06-30). Top holdings: CGON (22.12%), TNGX (15.79%), RVMD (7.48%). Among its top 25 positions this quarter: 2 new, 22 added, 1 trimmed.
| Rank | Ticker | Company | Value | % Portfolio | Shares | Action |
|---|---|---|---|---|---|---|
| 1 | CGON | CG ONCOLOGY INC | $134.0M | 22.12% | 1.9M | Added |
| 2 | TNGX | TANGO THERAPEUTICS INC | $95.7M | 15.79% | 3.2M | Added |
| 3 | RVMD | REVOLUTION MEDICINES INC | $45.3M | 7.48% | 242,029 | Added |
| 4 | PHVS | PHARVARIS N V | $26.8M | 4.42% | 774,501 | Added |
| 5 | LQDA | LIQUIDIA CORPORATION | $20.5M | 3.38% | 256,603 | Added |
| 6 | ELVN | ENLIVEN THERAPEUTICS INC | $18.5M | 3.06% | 365,386 | Added |
| 7 | ABVX | ABIVAX SA | $14.8M | 2.45% | 111,334 | Added |
| 8 | AVTX | AVALO THERAPEUTICS INC | $14.2M | 2.35% | 770,765 | Added |
| 9 | MIRM | MIRUM PHARMACEUTICALS INC | $12.9M | 2.13% | 110,393 | New |
| 10 | ASMB | ASSEMBLY BIOSCIENCES INC | $11.9M | 1.96% | 433,147 | Added |
| 11 | IPSC | CENTURY THERAPEUTICS INC | $10.7M | 1.76% | 4.3M | Added |
| 12 | CYTK | CYTOKINETICS INC | $10.1M | 1.66% | 118,240 | Added |
| 13 | TSHA | TAYSHA GENE THERAPIES INC | $9.9M | 1.64% | 1.5M | Added |
| 14 | MANE | VERADERMICS INC | $9.8M | 1.62% | 80,000 | New |
| 15 | AVBP | ARRIVENT BIOPHARMA INC | $8.6M | 1.41% | 246,606 | Added |
| 16 | TARS | TARSUS PHARMACEUTICALS INC | $7.9M | 1.31% | 117,067 | Added |
| 17 | ROIV | ROIVANT SCIENCES LTD | $7.8M | 1.29% | 220,126 | Added |
| 18 | XNCR | XENCOR INC | $7.8M | 1.29% | 368,305 | Added |
| 19 | DMRA | DAMORA THERAPEUTICS INC | $7.4M | 1.22% | 284,430 | Added |
| 20 | AXSM | AXSOME THERAPEUTICS INC | $7.1M | 1.16% | 28,826 | Added |
| 21 | DFTX | DEFINIUM THERAPEUTICS INC | $7.0M | 1.15% | 148,647 | Added |
| 22 | DNTH | DIANTHUS THERAPEUTICS INC | $6.3M | 1.04% | 64,723 | Added |
| 23 | COGT | COGENT BIOSCIENCES INC | $5.7M | 0.94% | 147,510 | Trimmed |
| 24 | ERAS | ERASCA INC | $5.6M | 0.93% | 308,007 | Added |
| 25 | NERV | MINERVA NEUROSCIENCES INC | $5.6M | 0.92% | 1.0M | Added |
Source: SEC Form 13F filings · as of 2026-06-30
Every position in this 13F-HR, with its change from the prior quarter.
13F holdings, latest quarter
SourceSEC EDGAR13F-HR